|
---|
Category:Letter
MONTHYEARML24019A2012024-01-19019 January 2024 Fourth 10-Year Interval, Second Period Owners Activity Report Number 1R24 ML24019A1362024-01-18018 January 2024 Inservice Inspection Request for Information ML24012A2452024-01-12012 January 2024 Response to Request for Additional Information to Proposed Method to Manage Environmentally Assisted Fatigue for the Pressurizer Surge Line ML24010A1532024-01-10010 January 2024 Information Request for the Cybersecurity Baseline Inspection, Notification to Perform Inspection ML23341A0062023-12-21021 December 2023 Project Manager Assignment IR 05000528/20230112023-12-18018 December 2023 License Renewal Inspection Report 05000528/2023011 ML23335A0782023-11-30030 November 2023 Independent Spent Fuel Storage Installation - Request for Exemption from Enhanced Weapons, Firearms Background Checks, and Security Event Notifications Implementation ML23325A1602023-11-17017 November 2023 Supplemental Submittal - Relief Request 70 Proposed Alternatives for Pressurizer Lower Shell Temperature Nozzle IR 05000528/20234032023-11-13013 November 2023 NRC Security Inspection Report 05000528 2023403, 05000529 2023403, 05000530 2023403 (Full Report) ML23311A2082023-11-0909 November 2023 Reassignment of U.S. Nuclear Regulatory Commission Branch Chief in the Division of Operating Reactor Licensing for Plant Licensing Branch IV ML23299A3052023-10-26026 October 2023 Response to Request for Additional Information Relief Request 70 Proposed Alternatives for Pressurizer Lower Shell Temperature Nozzle IR 05000528/20230032023-10-17017 October 2023 Integrated Inspection Report 05000528 2023003 and 05000529 2023003 and 05000530 2023003 ML23270B9232023-09-28028 September 2023 Notification of Age-Related Degradation Inspection (05000528/2024012, 05000529/2024012, and 05000530/2024012) and Request for Information ML23251A2332023-09-13013 September 2023 Notification of Post Approval Site Inspection for License Renewal and Request for Information Inspection (05000528/2023011) ML23241B0182023-09-13013 September 2023 Use of Honeywell Mururoa V4F1 and MTH2 Supplied Air Suits within Respiratory Protection Program IR 05000528/20243012023-09-0606 September 2023 Notification of NRC Initial Operator Licensing Examination 05000528/2024301; 05000529/2024301; 05000530/2024301 IR 05000528/20230102023-08-22022 August 2023 Biennial Problem Identification and Resolution Inspection Report 05000528/2023010, 05000529/2023010 and 05000530/2023010 IR 05000528/20230052023-08-21021 August 2023 Updated Inspection Plan for Palo Verde Nuclear Generating Station, Units 1, 2, and 3 (Report 05000528/2023005 and 05000529/2023005 and 05000530/2023005) ML23222A2762023-08-10010 August 2023 Independent Spent Fuel Storage Installation, Registration of Dry Spent Fuel Transportable Storage Canister Identification Numbers AMZDFX175 and AMZDFX176 and Vertical Concrete Cask Identification Numbers AMZDNE175, and AMZDNE176 ML23199A2942023-08-0909 August 2023 Issuance of Amendment Nos. 221, 221, and 221, to Revise Technical Specifications to Adopt TSTF-107, Separate Control Rods That Are Untrippable Versus Inoperable IR 05000528/20230022023-08-0808 August 2023 Integrated Inspection Report 05000528/2023002 and 05000529/2023002 and 05000530/2023002 ML23207A2482023-07-26026 July 2023 License Renewal Pressurizer Surge Line Inspection ML23188A1872023-07-0707 July 2023 Fourth 10-Year Interval, Second Period Owners Activity Report Number 2R24 ML23166B0832023-07-0505 July 2023 Independence Spent Fuel Storage Installation - Issuance of Exemption ML23181A1602023-06-30030 June 2023 2 to Updated Final Safety Analysis Report, and Revision 3 to Operations Quality Assurance Program Description ML23180A2222023-06-29029 June 2023 Application to Revise Technical Specifications (TS) 3.5.1, Safety Injection Tanks (Sits) - Operating, TS 3.5.2, Safety Injection Tanks (Sits) - Shutdown, and TS 3.6.5, Containment Air Temperature ML23181A0772023-06-29029 June 2023 Program Review - Simulator Testing Methodology ML23157A1292023-06-0101 June 2023 Annual Report of Guarantee of Payment of Deferred Premium ML23144A3722023-05-24024 May 2023 Response to Regulatory Issue Summary (RIS) 2023-01, Preparation and Scheduling of Operator Licensing Examinations ML23143A3912023-05-23023 May 2023 Independent Spent Fuel Storage Installation - Request for Exemption from NAC-MAGNASTOR Certificate of Compliance 72-1031 - Cask Lid Batch 3 Design Requirements ML23145A2772023-05-17017 May 2023 10-PV-2023-05 Post-Exam Comments ML23132A3392023-05-12012 May 2023 Application to Revise Technical Specifications 3.3.11 to Adopt TSTF-266-A, Revision 3, Eliminate the Remote Shutdown System Table of Instrumentation and Controls IR 05000528/20230012023-05-0808 May 2023 and Independent Spent Fuel Storage Installation - Integrated Inspection Report 05000528/2023001 and 05000529/2023001 and 05000530/2023001 and 07200044/2023001 ML23128A0692023-05-0808 May 2023 Notification of Biennial Problem Dentification and Resolution Inspection and Request for Information ML23122A1822023-04-29029 April 2023 Transmittal of Technical Specification Bases Revision 76 ML23122A1912023-04-29029 April 2023 Unit 1 Core Operating Limits Report Revision 32, Unit 2 Core Operating Limits Report Revision 25, Unit 3 Core Operating Limits Report Revision 31 ML23116A2772023-04-26026 April 2023 Independent Spent Fuel Storage Installation, Annual Radioactive Effluent Release Report 2022 ML23115A4012023-04-26026 April 2023 Review of the 2022 Steam Generator Tube Inspections During Refueling Outage 23 ML23115A4982023-04-25025 April 2023 2022 Annual Environmental Operating Report IR 05000528/20230122023-04-19019 April 2023 Notification of Commercial Grade Dedication Inspection (05000528/2023012, 05000529/2023012, and 05000530/2023012) and RFI ML23108A0342023-04-18018 April 2023 NRC Initial Operator Licensing Examination Approval 05000528/2023301; 05000529/2023301; 05000530/2023301 ML23103A4642023-04-13013 April 2023 Annual Radiological Environmental Operating Report 2022 ML23103A4312023-04-13013 April 2023 Emergency Core Cooling System Performance Evaluation Models, 10 CFR 50.46(a)(3)(ii) Annual Report for 2022 IR 05000528/20224012023-04-13013 April 2023 Cyber Security Inspection Report 05000528/2022401 and 05000529/2022401 and 05000530/2022401 ML23102A3292023-04-12012 April 2023 Application for Authorized Use of Mururoa Single-Use, Supplied Air Suits, Models V4F1 and MTH2 ML23102A3242023-04-12012 April 2023 Supplement to Application to Revise Technical Specifications to Adopt TSTF-107-A, Separate Control Rods That Are Untrippable Versus Inoperable ML23089A4002023-03-30030 March 2023 Consolidated Decommissioning Funding Status Report - 2022 ML23088A4012023-03-30030 March 2023 Project Manager Assignment IR 05000528/20234022023-03-29029 March 2023 and 3 - NRC Security Inspection Report 05000528-2023402, 05000529-2023402, and 05000530-2023402, (Cover Letter Only) ML23080A3002023-03-21021 March 2023 Present Levels of Financial Protection 2024-01-19
[Table view] Category:License-Fitness for Duty (FFD) Performance Report
MONTHYEARML24019A1462024-01-19019 January 2024 Single Positive Test Form Collected on 1/19/2024 ML24011A1102024-01-11011 January 2024 Annual Report Form for Drug and Alcohol Tests for 2023 ML24011A1112024-01-11011 January 2024 Annual Fatigue Report Form for 2023 ML23349A0632023-12-15015 December 2023 Single Positive Test Form Collected on 10/26/2023 ML23349A0542023-12-15015 December 2023 Single Positive Test Form Collected on 11/14/2023 ML23348A3452023-12-14014 December 2023 Single Positive Test Form Collected on 11/14/2023 ML23348A3422023-12-14014 December 2023 Single Positive Test Form Collected on 11/5/2023 ML23348A3442023-12-14014 December 2023 Single Positive Test Form Collected on 10/27/2023 ML23348A3432023-12-14014 December 2023 Single Positive Test Form Collected on 10/17/2023 ML23290A2582023-10-17017 October 2023 Single Positive Test Form Collected on 10/3/2023 ML23285A2752023-10-12012 October 2023 Single Positive Test Form Collected on 9/19/2023 ML23285A2772023-10-12012 October 2023 Single Positive Test Form Collected on 9/20/2023 ML23285A2782023-10-12012 October 2023 Single Positive Test Form Collected on 9/19/2023 ML23285A2762023-10-12012 October 2023 Single Positive Test Form Collected on 9/20/2023 ML23285A2792023-10-12012 October 2023 Single Positive Test Form Collected on 9/28/2023 ML23261A7522023-09-18018 September 2023 Single Positive Test Form Collected on 8/16/2023 ML23261A7512023-09-18018 September 2023 Single Positive Test Form Collected on 08/29/2023 ML23222A0952023-08-10010 August 2023 Single Positive Test Form Collected on 7/18/2023 ML23222A0942023-08-10010 August 2023 Single Positive Test Form Collected on 7/27/2023 ML23200A1192023-07-19019 July 2023 Single Positive Test Form Collected on 6/30/2023 ML23125A1542023-05-0505 May 2023 Single Positive Test Form Collected on 4/28/2023 ML23109A3502023-04-19019 April 2023 Single Positive Test Form Collected on 4/3/2023 ML23109A3542023-04-19019 April 2023 Single Positive Test Form Collected on 3/30/2023 ML23109A3522023-04-19019 April 2023 Single Positive Test Form Collected on 3/22/2023 ML23109A3572023-04-19019 April 2023 Single Positive Test Form Collected on 4/6/2023 ML23109A3482023-04-19019 April 2023 Single Positive Test Form Collected on 4/6/2023 ML23109A3582023-04-19019 April 2023 Single Positive Test Form Collected on 3/30/2023 ML23109A3492023-04-19019 April 2023 Single Positive Test Form Collected on 4/15/2023 ML23109A3532023-04-19019 April 2023 Single Positive Test Form Collected on 3/27/2023 ML23109A3562023-04-19019 April 2023 Single Positive Test Form Collected on 3/27/2023 ML23109A3512023-04-19019 April 2023 Single Positive Test Form Collected on 3/27/2023 ML23109A3552023-04-19019 April 2023 Single Positive Test Form Collected on 3/27/2023 ML23089A1992023-03-30030 March 2023 Single Positive Test Form Collected on 9/27/2022 ML23089A1982023-03-30030 March 2023 Single Positive Test Form Collected on 5/10/2022 ML23089A2662023-03-30030 March 2023 Annual Report Form for Drug and Alcohol Tests for 2022 ML23089A2002023-03-30030 March 2023 Single Positive Test Form Collected on 3/25/2022 ML23089A2092023-03-30030 March 2023 Single Positive Test Form Collected on 7/8/2022 ML23083B4002023-03-24024 March 2023 Single Positive Test Form Collected on 3/9/2023 ML23074A1492023-03-15015 March 2023 (50-528, 50-529, 50-530), Single Positive Test Form Collected on 1/4/2023 ML23074A1512023-03-15015 March 2023 (50-528, 50-529, 50-530), Single Positive Test Form Collected on 2/10/2023 ML23052A1702023-02-15015 February 2023 (50-528, 50-529, 50-530), Single Positive Test Form Collected on 2/7/2023 ML23046A2582023-02-10010 February 2023 Annual Fatigue Reporting Form for 2022 ML23046A2392023-02-0909 February 2023 Single Positive Test Form Collected on 09/20/2022 ML23046A2382023-02-0909 February 2023 Single Positive Test Form Collected on 09/23/2022 2024-01-19
[Table view] |
Text
10 CFR 26.719 BRUCE J. RASH Vice President Nuclear Engineering/Regulatory Palo Verde Nuclear Generating Station P.O. Box 52034 Phoenix, AZ 85072 Mail Station 7605 Tel 623 393 6491 102-08199-BR/LMW December 30, 2020 ATTN: Document Control Desk U.S. Nuclear Regulatory Commission Washington, DC 20555-0001
Dear Sirs:
Subject:
Palo Verde Nuclear Generating Station (PVNGS)
Units 1, 2, and 3 Docket Nos. STN 50-528/529/530 Unanticipated Result for a FFD Performance Test Sample Pursuant to 10 CFR 26.719(c)(1), Arizona Public Service (APS) Company hereby provides, as an enclosure to this letter, a report of an unanticipated result for a Fitness for Duty (FFD) performance test sample.
On July 29, 2020, the PVNGS FFD collection facility received from a Department of Health and Human Services (HHS) certified laboratory, a performance test result that was not consistent with the expected result. APS completed its investigation on December 2, 2020. Results of the investigation are documented in the enclosure to this letter.
APS makes no commitments in this letter. If you have questions regarding this submittal, please contact Matthew Kura, Department Leader, Nuclear Regulatory Affairs, at (623) 393-5379.
Sincerely, Digitally signed by Rash, Rash, Bruce Bruce (Z77439)
DN: cn=Rash, Bruce (Z77439)
(Z77439) Date: 2020.12.30 09:58:55
-07'00' BR/LMW Enclosure cc: S. A. Morris NRC Region IV Regional Administrator S. P. Lingam NRC NRR Project Manager for PVNGS C. A. Peabody NRC Senior Resident Inspector PVNGS
$PHPEHURIWKH67$56$OOLDQFH//&
&DOODZD\'LDEOR&DQ\RQ3DOR9HUGH:ROI&UHHN
ENCLOSURE Unanticipated Result for a FFD Performance Test Sample
ENCLOSURE Unanticipated Result for a FFD Performance Test Sample Description In accordance with 10 CFR 26.168, Arizona Public Service Company (APS) provides performance test samples which are submitted to the two contracted Department of Health and Human Services (HHS) certified laboratories for Fitness for Duty (FFD) specimen analysis for the Palo Verde Nuclear Generating Station (PVNGS) FFD program. The two laboratories are MedTox Laboratories Incorporated (MedTox) and Laboratory Corporation of America Holdings (LabCorp).
APS provided a split of two blind samples to both laboratories which were prepared from the same batch and positive for cocaine metabolite (benzoylecgonine). Each split sample was provided on July 28, 2020.
On July 29, 2020, the PVNGS FFD department received a laboratory report from MedTox that indicated a Negative/Normal test result for the blind test sample that was expected to indicate Normal/Positive.
The LabCorp blind test sample result was reported back as positive for benzoylecgonine on July 31, 2020, as anticipated.
The unanticipated performance test result from MedTox represented an unsatisfactory condition that was investigated by APS. The evaluation was completed on December 2, 2020. This report is submitted to the Nuclear Regulatory Commission (NRC) pursuant to 10 CFR 26.719(c)(1), to describe the condition and corrective actions, taken or planned.
Investigation Results Following the review of test results by the Medical Review Officer (MRO),
MedTox was notified on August 5, 2020, that the blind sample results were inconsistent with the expected result of Positive for Cocaine Metabolite.
APS also requested that MedTox perform re-confirmatory testing of an aliquot of the original split blind sample that was sent to LabCorp on July 28, 2020. Upon receipt of the aliquot, MedTox analyzed the blind sample and reported a positive result for benzoylecgonine, which was consistent with the expected result.
MedTox performed an investigation to determine the cause of the failure and provide an explanation of corrective actions taken.
Through their investigation, MedTox concluded that While it is possible that a mixing or an undetected sampling error could have occurred, the original specimen was disposed of prior to notification of the error so additional/repeat testing could not be performed to provide additional insight into the discrepancy.
Page 1 of 2
ENCLOSURE Unanticipated Result for a FFD Performance Test Sample On December 2, 2020, based on the MedTox investigation results and further correspondence, the investigation was considered completed although a definitive cause was not identified.
Actions Taken MedTox requested a special internal proficiency test set submitted as internal blind samples through their Quality Assurance (QA) department to monitor the assay performance. Two sets of double blind quality control samples (three per set) were submitted. These samples were received and tested as routine donor samples. The internal blind performance testing completed by MedTox revealed anticipated performance results.
Page 2 of 2